Search Results - R. A. Abdulkhakov
-
1
Clinical-pathomorphological characteristic of stomach ulcer with different sizes of ulcerous defects
Published 2005-12-01Get full textIt was studied 58 patients with medium size ulcer and 182 with big size ulcers in order to compare activity of stomach ulcer and duodenum disease of patients with medium and big ulcerous defects and discover its peculiarities depending on sizes of ulcers. It was discovered that big size ulcers occur...
Article -
2
Complications of stomach ulcer with different dimensions of ulcerous defects
Published 2005-12-01Get full textIt was studied development of complications among 240 patients with stomach ulcer and duodenum disease with different sizes of ulcerous defects. It was discovered that among patients with big size ulcers complications occur more frequently and depend on duration of disease; bleeding is among the mos...
Article -
3
Intestinal Permeability Assays: a Review
Published 2021-04-01Get full textAim. A literature review of intestinal permeability assessment techniques.Key points. The intestinal barrier is a functional entity separating the intestinal lumen and internal body, and intestinal permeability is a measure of the barrier functionality. The intestinal barrier integrity and permeabil...
Article -
4
Peculiarities of polymorphism of <i>Helicobacter pylori</i> virulence genes and IL-1 genes in peptic ulcer of stomach and duodenum, associated with <i>Helicobacter pylori</i>
Published 2005-12-01Get full textThe prevalence of H.pylori virulence genes (iceA, cagA, babA2, vacA) as well as the distribution of the IL-1 genes was studied in patients with H.pylori-associated gastric and duodenal ulcer disease. VacA s1/m2 iceA1 cagA+ и vacA s1/m2 iceA1 cagA+ babA2 genotypes of H. pylori were shown to be preval...
Article -
5
Treatment of Helicobacter pylori infection: mainstream and innovations (Review of the literature and Russian gastroenterological association Advisory council resolution, May 19, 20...
Published 2018-08-01Get full textAim of review. To present data of clinical trials, systematic reviews and metaanalyses which allow to optimize eradication therapy of Helicobacter pylori (H. pylori) infection. Summary. Standard triple therapy including proton pump inhibitor (PPI), clarithromycin and amoxicillin is the firstline tr...
Article -
6
Application of dexlansoprazole to broaden therapeutic options for gastroesophageal reflux disease
Published 2015-12-01Get full text.
Article -
7
COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patient...
Published 2023-12-01Get full textAim: to study the effectiveness and safety of using the drug Kolofort® in outpatients with irritable bowel syndrome (IBS) after a new coronavirus infection.Materials and methods. An observational non-interventional program was conducted in patients with exacerbation of IBS symptoms after a new coron...
Article -
8
Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018)
Published 2018-08-01Get full textAim of review. To present management approach for acid-related diseases in patients with Helicobacter pylori (H. pylori) infection, under long-term proton pump inhibitor therapy. Summary. There is no relation of gastroesophageal reflux disease (GERD) symptom severity, the pattern of relapses and tre...
Article -
9
Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
Published 2018-08-01Get full textAim of publication. To present indications for antihelicobacter therapy, methods and sequence of diagnostics and eradication treatment of Helicobacter pylori (H. pylori) infection to general practitioners. Key points. Chronic gastritis caused by H. pylori infection, including that in «asymptomatic»...
Article -
10
Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized plac...
Published 2018-08-01Get full textAim of investigation. To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and methods. Original study included overall 180 patients w...
Article -
11
Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis
Published 2021-12-01Get full textAim. The clinical guidelines are intended to supplement specialty decision-making for improved aid quality in patients with gastritis and duodenitis though acknowledging the latest clinical evidence and principles of evidencebased medicine.Key points. Gastritis is an inflammatory disease of stomach...
Article